A PARSIMONIOUS APPROACH TO QUALIFICATION OF SERUM PROTEOMIC BIOMARKERS FOR PREDICTING OSTEOARTHRITIS PROGRESSION

被引：0
|
作者：
Reed, A. [1 ]
Li, Y. -J. [1 ,2 ]
Soderblom, E. [3 ]
Moseley, A. [3 ]
Attur, M. [4 ]
Abramsom, S. [4 ]
Samuels, J. [4 ]
Krauss, V. B. [1 ,5 ]
机构：
[1] Duke Mol Physiol Inst, Durham, NC USA
[2] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA
[3] Duke Ctr Genom & Computat Biol, Durham, NC USA
[4] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA
[5] Duke Univ, Dept Med, Durham, NC USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2020年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
471
引用
收藏
页码：S326 / S326
页数：1
相关论文
共 50 条
  • [31] Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis
    Akinmade, Akinola
    Oginni, Lawrence M.
    Adegbehingbe, Olayinka O.
    Okunlola, Abiodun I.
    Jeje, Olusola A.
    Adeyeye, Adeolu I.
    INTERNATIONAL ORTHOPAEDICS, 2021, 45 (03) : 551 - 557
  • [32] A Highly Sensitive Proteomic Immunoassay to Identify Novel Serum Biomarkers for Multiple Sclerosis Disease Progression
    Van Lierop, Z.
    In't Veld, S.
    Noteboom, S.
    Willemse, E.
    Schoonheim, M.
    Steenwijk, M.
    Geurts, J.
    Uitdehaag, B.
    Killestein, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 155 - 155
  • [33] Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis
    Akinola Akinmade
    Lawrence M. Oginni
    Olayinka O. Adegbehingbe
    Abiodun I. Okunlola
    Olusola A. Jeje
    Adeolu I. Adeyeye
    International Orthopaedics, 2021, 45 : 551 - 557
  • [34] Identification of Osteoarthritis Biomarkers by Proteomic Analysis of Synovial Fluid
    Han, M. Y.
    Dai, J. J.
    Zhang, Y.
    Lin, Q.
    Jiang, M.
    Xu, X. Y.
    Liu, Q.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (06) : 2243 - 2250
  • [35] Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach
    Rawal, Neetu
    Hariprasad, Gururao
    Bandyopadhyay, Sabyasachi
    Dash, Nihar Ranjan
    Kumar, Sunil
    Das, Prasenjit
    Dey, Sharmistha
    Khan, Maroof Ahmad
    Ranjan, Amar
    Chopra, Anita
    Saluja, Sundeep
    Hussain, Showket
    Rath, G. K.
    Kaur, Tanvir
    Tanwar, Pranay
    BIOMOLECULES AND BIOMEDICINE, 2024, 25 (01): : 115 - 143
  • [36] Serum and CSF Biomarkers of Progression
    Gresle, Melissa
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 800 - 800
  • [37] Metabolic Profiling of Serum for Osteoarthritis Biomarkers
    Xiao, Ziqian
    Zhang, Zhenyang
    Huang, Shanbin
    Lon, Jerome Rumdon
    Xie, Shuilin
    DISEASE MARKERS, 2022, 2022
  • [38] Modeling and predicting osteoarthritis progression: data from the osteoarthritis initiative
    Halilaj, E.
    Le, Y.
    Hicks, J. L.
    Hastie, T. J.
    Delp, S. L.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 (12) : 1643 - 1650
  • [39] Comparison of serum and csf fluid biomarkers for predicting long term disease progression in ms
    Thebault, S.
    Abdoli, M.
    Fereshtehnejad, S. M.
    Tessier, D.
    Tabard-Cossa, V.
    Freedman, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 142 - 142
  • [40] Proteomic Discovery of Serum Biomarkers for Human Leiomyosarcoma
    Alkelani, Hiba
    Bateman, Nicholas W.
    Garcia, Natalia
    Ulin, Mara
    Bariani, Maria Victoria
    Yang, Qiwei
    Conrads, Kelly A.
    Hood, Brian L.
    Barakat, Waleed
    Conrads, Thomas P.
    Maxwell, George L.
    Al-Hendy, Ayman
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 62 - 63
12345